A comprehensive screening for PD-L1 expression in thyroid cancer found that only 6.6% of cases expressed PD-L1 at 1% threshold, with higher positivity in follicular and anaplastic carcinomas (37). Here, CD274 is linked to undifferentiated carcinoma.